IBDEI0NR ; ; 12-AUG-2014
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;MAY 15, 2014
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11695,1,2,0)
 ;;=2^ANEURYSM,AORTIC W/O RUPTURE
 ;;^UTILITY(U,$J,358.3,11695,2)
 ;;=^9277
 ;;^UTILITY(U,$J,358.3,11696,0)
 ;;=442.9^^79^768^3
 ;;^UTILITY(U,$J,358.3,11696,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11696,1,1,0)
 ;;=1^442.9
 ;;^UTILITY(U,$J,358.3,11696,1,2,0)
 ;;=2^ANEURYSM,NON-AORTIC
 ;;^UTILITY(U,$J,358.3,11696,2)
 ;;=^7390
 ;;^UTILITY(U,$J,358.3,11697,0)
 ;;=710.3^^79^768^4
 ;;^UTILITY(U,$J,358.3,11697,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11697,1,1,0)
 ;;=1^710.3
 ;;^UTILITY(U,$J,358.3,11697,1,2,0)
 ;;=2^DERMATOMYOSITIS
 ;;^UTILITY(U,$J,358.3,11697,2)
 ;;=^33162
 ;;^UTILITY(U,$J,358.3,11698,0)
 ;;=446.5^^79^768^5
 ;;^UTILITY(U,$J,358.3,11698,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11698,1,1,0)
 ;;=1^446.5
 ;;^UTILITY(U,$J,358.3,11698,1,2,0)
 ;;=2^GIANT CELL ARTERITIS
 ;;^UTILITY(U,$J,358.3,11698,2)
 ;;=^117658
 ;;^UTILITY(U,$J,358.3,11699,0)
 ;;=446.20^^79^768^6
 ;;^UTILITY(U,$J,358.3,11699,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11699,1,1,0)
 ;;=1^446.20
 ;;^UTILITY(U,$J,358.3,11699,1,2,0)
 ;;=2^HYPERSENSITIVITY ANGIITIS, UNS
 ;;^UTILITY(U,$J,358.3,11699,2)
 ;;=^60279
 ;;^UTILITY(U,$J,358.3,11700,0)
 ;;=446.3^^79^768^7
 ;;^UTILITY(U,$J,358.3,11700,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11700,1,1,0)
 ;;=1^446.3
 ;;^UTILITY(U,$J,358.3,11700,1,2,0)
 ;;=2^LETHAL MIDLINE GRANULOMA
 ;;^UTILITY(U,$J,358.3,11700,2)
 ;;=^52905
 ;;^UTILITY(U,$J,358.3,11701,0)
 ;;=446.1^^79^768^8
 ;;^UTILITY(U,$J,358.3,11701,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11701,1,1,0)
 ;;=1^446.1
 ;;^UTILITY(U,$J,358.3,11701,1,2,0)
 ;;=2^MUCOCUTANEOUS LYMPH SYND (MCLS)
 ;;^UTILITY(U,$J,358.3,11701,2)
 ;;=^79494
 ;;^UTILITY(U,$J,358.3,11702,0)
 ;;=443.9^^79^768^12
 ;;^UTILITY(U,$J,358.3,11702,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11702,1,1,0)
 ;;=1^443.9
 ;;^UTILITY(U,$J,358.3,11702,1,2,0)
 ;;=2^PERIPH VASCULAR DIS NOS
 ;;^UTILITY(U,$J,358.3,11702,2)
 ;;=^184182
 ;;^UTILITY(U,$J,358.3,11703,0)
 ;;=446.0^^79^768^13
 ;;^UTILITY(U,$J,358.3,11703,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11703,1,1,0)
 ;;=1^446.0
 ;;^UTILITY(U,$J,358.3,11703,1,2,0)
 ;;=2^POLYARTERITIS NODOSA
 ;;^UTILITY(U,$J,358.3,11703,2)
 ;;=^91874
 ;;^UTILITY(U,$J,358.3,11704,0)
 ;;=710.4^^79^768^14
 ;;^UTILITY(U,$J,358.3,11704,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11704,1,1,0)
 ;;=1^710.4
 ;;^UTILITY(U,$J,358.3,11704,1,2,0)
 ;;=2^POLYMYOSITIS
 ;;^UTILITY(U,$J,358.3,11704,2)
 ;;=^186822
 ;;^UTILITY(U,$J,358.3,11705,0)
 ;;=452.^^79^768^15
 ;;^UTILITY(U,$J,358.3,11705,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11705,1,1,0)
 ;;=1^452.
 ;;^UTILITY(U,$J,358.3,11705,1,2,0)
 ;;=2^PORTAL VEIN THROMBOSIS
 ;;^UTILITY(U,$J,358.3,11705,2)
 ;;=^269815
 ;;^UTILITY(U,$J,358.3,11706,0)
 ;;=714.2^^79^768^16
 ;;^UTILITY(U,$J,358.3,11706,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11706,1,1,0)
 ;;=1^714.2
 ;;^UTILITY(U,$J,358.3,11706,1,2,0)
 ;;=2^RHEUMATOID ARTHRITIS,SYSTEMIC
 ;;^UTILITY(U,$J,358.3,11706,2)
 ;;=^272111
 ;;^UTILITY(U,$J,358.3,11707,0)
 ;;=135.^^79^768^17
 ;;^UTILITY(U,$J,358.3,11707,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11707,1,1,0)
 ;;=1^135.
 ;;^UTILITY(U,$J,358.3,11707,1,2,0)
 ;;=2^SARCOIDOSIS
 ;;^UTILITY(U,$J,358.3,11707,2)
 ;;=^107916
 ;;^UTILITY(U,$J,358.3,11708,0)
 ;;=710.0^^79^768^18
 ;;^UTILITY(U,$J,358.3,11708,1,0)
 ;;=^358.31IA^2^2
 ;;^UTILITY(U,$J,358.3,11708,1,1,0)
 ;;=1^710.0
 ;;^UTILITY(U,$J,358.3,11708,1,2,0)
 ;;=2^SYST LUPUS ERYTHEMATOSIS
 ;;^UTILITY(U,$J,358.3,11708,2)
 ;;=^72159
 ;;^UTILITY(U,$J,358.3,11709,0)
 ;;=710.1^^79^768^19
 ;;^UTILITY(U,$J,358.3,11709,1,0)
 ;;=^358.31IA^2^2
